Russell Investments Group
IMNM icon

Russell Investments Group’s Immunome IMNM Stock Holding History

Russell Investments Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Buy
29,961
+21,895
+271% +$469K ﹤0.01% 2678
2026
Q1 		$176K Buy
8,066
+649
+9% +$14.4K ﹤0.01% 2885
2025
Q4 		$159K Buy
7,417
+935
+14% +$16.4K ﹤0.01% 2913
2025
Q3 		$75.9K Buy
+6,482
New +$64.5K ﹤0.01% 3126
2024
Q4 		– Sell
-46
Closed -$673 – 3746
2024
Q3 		$673 Buy
+46
New +$654 ﹤0.01% 3531

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Russell Investments Group's IMNM Position: Q2 2026 in Review

Russell Investments Group increased its Immunome (IMNM) stake by 271% in Q2 2026, buying an estimated $469K and bringing the position to 29,961 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

Russell Investments Group first reported a position in IMNM in Q3 2024 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Russell Investments Group held 29,961 shares of Immunome worth $635K as of Q2 2026.
  • Russell Investments Group bought 21,895 Immunome shares in Q2 2026, an estimated $469K.
  • Immunome made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2678 holding.
  • Russell Investments Group first reported a position in Immunome in Q3 2024 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.